MapLight Therapeutics (MPLT) Current Assets (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Current Assets came in at $324.7 million in Q4 2025, up 183.3% year-on-year from $114.6 million in Q4 2024, and up 32.35% quarter-over-quarter from $245.3 million in Q3 2025.
MapLight Therapeutics (MPLT) Current Assets (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Current Assets across 2 years of filings, most recently posting $324.7 million for Q4 2025.
- Current Assets for Q4 2025 came in at $324.7 million, up 183.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $324.7 million (up 183.3% YoY), and the FY2025 annual result was $324.7 million, up 183.3% from the prior year.
- Current Assets came in at $324.7 million for Q4 2025 at MapLight Therapeutics, up from $245.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $324.7 million in Q4 2025 to a low of $114.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 324.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 324.67 Mn |
| Sep 30, 2025 | 245.31 Mn |
| Dec 31, 2024 | 114.60 Mn |